About Supernus Pharmaceuticals
Supernus Pharmaceuticals, Inc. is an award-winning biopharmaceutical company specializing in the development and commercialization of innovative products targeting central nervous system (CNS) diseases. With over 30 years of industry experience, we have successfully established a portfolio that addresses significant health issues, such as epilepsy, ADHD, and Parkinson's disease. Our mission is to enhance the lives of patients suffering from CNS disorders through our dedicated research and development efforts, which are vital to our success.
At Supernus, our pipeline includes a variety of therapeutic candidates addressing large market opportunities in CNS conditions. We have marketed several products within the United States through our own specialized sales force while also pursuing strategic collaborations globally. Our commitment to patient care and innovative science drives us to improve therapies continuously and to bring forward additional treatment options that can drastically change the healthcare landscape for millions.
FAQs
- Which countries does Supernus Pharmaceuticals have remote employees in?
- Supernus Pharmaceuticals has employees in United States.
- When was Supernus Pharmaceuticals founded?
- Supernus Pharmaceuticals was founded in 2005.
- How many employees does Supernus Pharmaceuticals have?
- Supernus Pharmaceuticals has 201-500 employees.
- What industries or markets does Supernus Pharmaceuticals operate in?
- Supernus Pharmaceuticals operates in the following markets: Central Nervous System Disorders, Neurology, Epilepsy Treatment, ADHD Treatment, Parkinson's Disease Treatment, Drug Development, Healthcare, Life Sciences, Pharmaceutical, and Biopharma.
- What is Supernus Pharmaceuticals's website?
- Supernus Pharmaceuticals's website is supernus.com.
- Where can I find Supernus Pharmaceuticals on social media?
- You can find Supernus Pharmaceuticals on LinkedIn.